Cesano Alessandra — SEC insider filings

SEC reporting owner CIK 1827015. 19 insider filings on record with FilingPulse; latest filed 2026-09-16.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2021-01-11 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PUMA BIOTECHNOLOGY, INC. (PBYI)Director8—3 legs · 101,300 sh · $699,2137
Summit Therapeutics Inc. (SMMT)Director5——10
Zymeworks Inc. (ZYME)Director3——4
ESSA Pharma Inc. (EPIX)Chief Medical Officer3——3

Insider filings — Cesano Alessandra

FiledFormIssuerReported transactionsSource
2026-09-164PUMA BIOTECHNOLOGY, INC. (PBYI)Option exercise (M): 50,000 @ $2.93 · Sale (S): 62,150 @ $9.12 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2026-06-154PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2026-01-124Zymeworks Inc. (ZYME)Grant/award (A): 11,500 (derivative) @ $0 · Grant/award (A): 7,700 (derivative) @ $0EDGAR
2026-01-064Summit Therapeutics Inc. (SMMT)Grant/award (A): 35,000 (derivative) · Grant/award (A): 3,219 (derivative) @ $8.76EDGAR
2025-07-224PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 27,000 @ $3.37EDGAR
2025-06-174PUMA BIOTECHNOLOGY, INC. (PBYI)Sale (S): 12,150 @ $3.40EDGAR
2025-06-134PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2025-01-064Summit Therapeutics Inc. (SMMT)Grant/award (A): 35,000 (derivative) · Grant/award (A): 3,073 (derivative) @ $9.18EDGAR
2024-12-124Zymeworks Inc. (ZYME)Grant/award (A): 31,000 (derivative) @ $0EDGAR
2024-06-214PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2024-03-284ESSA Pharma Inc. (EPIX)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-02-094Zymeworks Inc. (ZYME)Grant/award (A): 74,000 (derivative) @ $0EDGAR
2024-01-044Summit Therapeutics Inc. (SMMT)Grant/award (A): 35,000 (derivative) · Grant/award (A): 21,363 (derivative) @ $1.32EDGAR
2023-06-154PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 27,000 @ $0EDGAR
2023-01-054Summit Therapeutics Inc. (SMMT)Grant/award (A): 35,000 (derivative) · Grant/award (A): 16,350 (derivative) @ $1.67EDGAR
2022-11-174Summit Therapeutics Inc. (SMMT)Grant/award (A): 200,000 (derivative) · Grant/award (A): 4,166 (derivative)EDGAR
2022-11-014ESSA Pharma Inc. (EPIX)Grant/award (A): 90,000 (derivative) @ $0EDGAR
2022-08-024PUMA BIOTECHNOLOGY, INC. (PBYI)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-01-114ESSA Pharma Inc. (EPIX)Grant/award (A): 57,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1827015 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs